HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / COM
Number of holders
335
Total Shares
136M
Shares change
+2.13M
Total reported value, excl. options
$5.82B
Value change
+$128M
Put/Call ratio
0.31
Number of buys
189
Number of sells
-126
Price
$42.71
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.